Search

everythinglearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Finasteride improves urinary symptoms and quality of life in BPH patients, especially with larger prostate size.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

Ganoderma lucidum may help treat enlarged prostate in rats.

Family doctors can manage older men with urinary symptoms using exams, tests, and medications.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Silver nanoparticles from Mitracarpus scaber protect the liver and reduce prostate enlargement.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Cuscuta reflexa extract may help treat benign prostatic hyperplasia by reducing inflammation and oxidative stress.

Early balding may be a sign of future prostate problems.

There is no link between hair loss and prostate enlargement.

Baldness (androgenic alopecia) could be a risk factor for prostate cancer.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.